AI-Guided Quantitative Plaque Staging Predicts Long-Term Cardiovascular Outcomes in Patients at Risk for Atherosclerotic CVD
Nick S. Nurmohamed(George Washington University), Paul Knaapen(Amsterdam University Medical Centers), Émilie Gaillard(Amsterdam University Medical Centers), James K. Min(Cornell University), Ruurt Jukema(Amsterdam University Medical Centers), Ibrahim Danad(Radboud University Nijmegen), James P. Earls(George Washington University), Ralf W. Sprengers(Amsterdam University Medical Centers), Ruben W. de Winter(Amsterdam University Medical Centers), Andrew Choi(Counties Manukau District Health Board), Roel S. Driessen(Amsterdam UMC Location VUmc), Erik S.G. Stroes(Amsterdam University Medical Centers), Pepijn A. van Diemen(Amsterdam UMC Location Vrije Universiteit Amsterdam), Rhanderson Cardoso(Brigham and Women's Hospital), Ron Blankstein(Brigham and Women's Hospital), Robin J. de Groot(Amsterdam University Medical Centers), Michiel J. Bom(Amsterdam UMC Location Vrije Universiteit Amsterdam)
Cited by 135
Related Papers
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
|European Heart Journal|2015|1.4k
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
|European Heart Journal|2022|1.3k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k